Mandating Drug Discounts for Patients and Increasing 340B Program Transparency.
This bill requires healthcare providers participating in the 340B drug discount program to pass the full savings they receive on prescription drugs directly to the patients. It also mandates annual public reporting by these entities detailing their drug purchase costs, revenues, and how any surplus funds generated from the program are spent. The goal is to ensure that the substantial discounts benefit patients and increase public accountability.
Key points
Covered entities must ensure patients receive drugs at a price no higher than the entity's purchase price minus any additional discounts.
Annual public reporting is required on 340B drug costs, revenues, and the use of any resulting financial surplus by participating entities.
Expired
Citizen Poll